Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Med Chem ; 67(10): 7825-7835, 2024 May 23.
Artículo en Inglés | MEDLINE | ID: mdl-38729623

RESUMEN

Cardiac myosin activation has been shown to be a viable approach for the treatment of heart failure with reduced ejection fraction. Here, we report the discovery of nelutroctiv (CK-136), a selective cardiac troponin activator intended for patients with cardiovascular conditions where cardiac contractility is reduced. Discovery of nelutroctiv began with a high-throughput screen that identified compound 1R, a muscle selective cardiac sarcomere activator devoid of phosphodiesterase-3 activity. Optimization of druglike properties for 1R led to the replacement of the sulfonamide and aniline substituents which resulted in improved pharmacokinetic (PK) profiles and a reduced potential for human drug-drug interactions. In vivo echocardiography assessment of the optimized leads showed concentration dependent increases in fractional shortening and an improved pharmacodynamic window compared to myosin activator CK-138. Overall, nelutroctiv was found to possess the desired selectivity, a favorable pharmacodynamic window relative to myosin activators, and a preclinical PK profile to support clinical development.


Asunto(s)
Contracción Miocárdica , Humanos , Animales , Contracción Miocárdica/efectos de los fármacos , Enfermedades Cardiovasculares/tratamiento farmacológico , Ratas , Relación Estructura-Actividad , Masculino , Descubrimiento de Drogas , Troponina/metabolismo , Ratones , Ratas Sprague-Dawley , Sulfonamidas/farmacología , Sulfonamidas/farmacocinética , Sulfonamidas/química , Sulfonamidas/uso terapéutico , Sulfonamidas/síntesis química
2.
J Org Chem ; 85(7): 4648-4662, 2020 04 03.
Artículo en Inglés | MEDLINE | ID: mdl-32126173

RESUMEN

We describe our design, synthesis, and chemical study of a set of functional epidithiodiketopiperazines (ETPs) and evaluation of their activity against five human cancer cell lines. Our structure-activity relationship-guided substitution of ETP alkaloids offers versatile derivatization while maintaining potent anticancer activity, offering exciting opportunity for their use as there are no examples of complex and potently anticancer (nM) ETPs being directly used as conjugatable probes or warheads. Our synthetic solutions to strategically designed ETPs with functional linkers required advances in stereoselective late-stage oxidation and thiolation chemistry in complex settings, including the application of novel reagents for dihydroxylation and cis-sulfidation of diketopiperazines. We demonstrate that complex ETPs equipped with a strategically substituted azide functional group are readily derivatized to the corresponding ETP-triazoles without compromising anticancer activity. Our chemical stability studies of ETPs along with cytotoxic evaluation of our designed ETPs against A549, DU 145, HeLa, HCT 116, and MCF7 human cancer cell lines provide insights into the impact of structural features on potency and chemical stability, informing future utility of ETPs in chemical and biological studies.


Asunto(s)
Antineoplásicos , Piperazinas , Antineoplásicos/farmacología , Línea Celular Tumoral , Proliferación Celular , Dicetopiperazinas/farmacología , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Piperazinas/farmacología , Relación Estructura-Actividad
3.
Org Lett ; 17(17): 4268-71, 2015 Sep 04.
Artículo en Inglés | MEDLINE | ID: mdl-26336940

RESUMEN

The first total synthesis of (+)-luteoalbusins A and B is described. Highly regio- and diastereoselective chemical transformations in our syntheses include a Friedel-Crafts C3-indole addition to a cyclotryptophan-derived diketopiperazine, a late-stage diketopiperazine dihydroxylation, and a C11-sulfidation sequence, in addition to congener-specific polysulfane synthesis and cyclization to the corresponding epipolythiodiketopiperazine. We also report the cytoxicity of both alkaloids, and closely related derivatives, against A549, HeLa, HCT116, and MCF7 human cancer cell lines.


Asunto(s)
Dicetopiperazinas/síntesis química , Alcaloides Indólicos/síntesis química , Indoles/síntesis química , Piperazinas/síntesis química , Ciclización , Dicetopiperazinas/química , Dicetopiperazinas/farmacología , Ensayos de Selección de Medicamentos Antitumorales , Células HeLa , Humanos , Alcaloides Indólicos/química , Alcaloides Indólicos/farmacología , Indoles/química , Indoles/farmacología , Estructura Molecular , Piperazinas/química , Piperazinas/farmacología , Estereoisomerismo
4.
Science ; 336(6082): 717-21, 2012 May 11.
Artículo en Inglés | MEDLINE | ID: mdl-22491093

RESUMEN

Osteoarthritis (OA) is a degenerative joint disease that involves the destruction of articular cartilage and eventually leads to disability. Molecules that promote the selective differentiation of multipotent mesenchymal stem cells (MSCs) into chondrocytes may stimulate the repair of damaged cartilage. Using an image-based high-throughput screen, we identified the small molecule kartogenin, which promotes chondrocyte differentiation (median effective concentration = 100 nM), shows chondroprotective effects in vitro, and is efficacious in two OA animal models. Kartogenin binds filamin A, disrupts its interaction with the transcription factor core-binding factor ß subunit (CBFß), and induces chondrogenesis by regulating the CBFß-RUNX1 transcriptional program. This work provides new insights into the control of chondrogenesis that may ultimately lead to a stem cell-based therapy for osteoarthritis.


Asunto(s)
Anilidas/farmacología , Cartílago Articular/citología , Condrocitos/efectos de los fármacos , Condrogénesis , Células Madre Mesenquimatosas/efectos de los fármacos , Osteoartritis/tratamiento farmacológico , Ácidos Ftálicos/farmacología , Anilidas/administración & dosificación , Anilidas/química , Anilidas/uso terapéutico , Animales , Bovinos , Núcleo Celular/metabolismo , Condrocitos/citología , Condrocitos/metabolismo , Condrocitos/fisiología , Proteínas Contráctiles/metabolismo , Subunidad alfa 2 del Factor de Unión al Sitio Principal/metabolismo , Subunidad beta del Factor de Unión al Sitio Principal/metabolismo , Modelos Animales de Enfermedad , Filaminas , Ensayos Analíticos de Alto Rendimiento , Humanos , Células Madre Mesenquimatosas/citología , Células Madre Mesenquimatosas/fisiología , Ratones , Proteínas de Microfilamentos/metabolismo , Osteoartritis/patología , Osteoartritis/fisiopatología , Ácidos Ftálicos/administración & dosificación , Ácidos Ftálicos/química , Ácidos Ftálicos/uso terapéutico , Regeneración , Bibliotecas de Moléculas Pequeñas , Relación Estructura-Actividad
7.
J Am Chem Soc ; 130(37): 12276-8, 2008 Sep 17.
Artículo en Inglés | MEDLINE | ID: mdl-18722431

RESUMEN

While bond formation processes have traditionally garnered the attention of the chemical community, methods facilitating bond breaking remain relatively undeveloped. We report a novel, transition-metal-free oxidative C-C bond cleavage process for a broad range of ester and dicarbonyl compounds involving carbanion addition to nitrosobenzene. ReactIR experiments on the nitrosobenzene-mediated oxidative decarboxylation of esters indicate the reaction proceeds via fragmentation of a previously unobserved oxazetidin-4-one heterocycle, characterized by an intense IR stretching frequency at 1846 cm-1. These mechanistic studies have allowed further expansion of this protocol to ketone cleavage reactions of a diverse array of beta-ketoester and 1,3-diketone substrates. The conceptual and mechanistic insights offered by this study are likely to provide a platform for further development of bond-breaking methodologies.


Asunto(s)
Azetidinas/química , Compuestos Nitrosos/química , Espectrofotometría Infrarroja/métodos , Ácidos Carboxílicos/química , Ésteres/química , Oxidación-Reducción
10.
J Org Chem ; 71(1): 416-9, 2006 Jan 06.
Artículo en Inglés | MEDLINE | ID: mdl-16388674

RESUMEN

[reaction: see text] We have proposed a pathway for the base-catalyzed reverse vinylogous aldol reaction of (-)-(4abeta,5beta)-4,4a,5,6,7,8-hexahydro-5-hydroxy-1,4a-dimethylnaphthalen-2(3H)-one [(-)-8] under Robinson annulation conditions. For confirmation, 4-(2,6-dimethyl-3-oxocyclohex-1-enyl)butanal (11) and 4-(2,6-dimethyl-5-oxocyclohex-1-enyl)butanal (12), both of which potentially produce enolate I, were synthesized regioselectively. Unexpectedly, 11 gave a complex mixture, including only a trace amount of (+/-)-8 (less than 5% yield), under these basic conditions. To the contrary, 12 cleanly afforded (+/-)-8 in 66% yield. This result provides evidence for our proposed mechanism of the above reaction.


Asunto(s)
Naftalenos/química , Compuestos Orgánicos/química , Compuestos de Vinilo/química , Catálisis , Estructura Molecular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA